JP2021532818A5 - - Google Patents

Info

Publication number
JP2021532818A5
JP2021532818A5 JP2021506562A JP2021506562A JP2021532818A5 JP 2021532818 A5 JP2021532818 A5 JP 2021532818A5 JP 2021506562 A JP2021506562 A JP 2021506562A JP 2021506562 A JP2021506562 A JP 2021506562A JP 2021532818 A5 JP2021532818 A5 JP 2021532818A5
Authority
JP
Japan
Prior art keywords
cells
hapten
car
antigen receptor
chimeric antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021506562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021532818A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/044981 external-priority patent/WO2020033272A1/en
Publication of JP2021532818A publication Critical patent/JP2021532818A/ja
Publication of JP2021532818A5 publication Critical patent/JP2021532818A5/ja
Priority to JP2024108743A priority Critical patent/JP2024138364A/ja
Pending legal-status Critical Current

Links

JP2021506562A 2018-08-06 2019-08-02 ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物 Pending JP2021532818A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024108743A JP2024138364A (ja) 2018-08-06 2024-07-05 ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862714928P 2018-08-06 2018-08-06
US62/714,928 2018-08-06
PCT/US2019/044981 WO2020033272A1 (en) 2018-08-06 2019-08-02 Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024108743A Division JP2024138364A (ja) 2018-08-06 2024-07-05 ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物

Publications (2)

Publication Number Publication Date
JP2021532818A JP2021532818A (ja) 2021-12-02
JP2021532818A5 true JP2021532818A5 (enExample) 2022-08-09

Family

ID=69415147

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021506562A Pending JP2021532818A (ja) 2018-08-06 2019-08-02 ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物
JP2024108743A Pending JP2024138364A (ja) 2018-08-06 2024-07-05 ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024108743A Pending JP2024138364A (ja) 2018-08-06 2024-07-05 ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物

Country Status (8)

Country Link
US (1) US20210317407A1 (enExample)
EP (1) EP3833363A4 (enExample)
JP (2) JP2021532818A (enExample)
KR (1) KR20210074274A (enExample)
CN (1) CN112789051A (enExample)
AU (1) AU2019319674A1 (enExample)
CA (1) CA3108778A1 (enExample)
WO (1) WO2020033272A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4282419A1 (en) 2012-12-20 2023-11-29 Purdue Research Foundation Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
AU2015243849B2 (en) 2014-04-10 2020-12-17 Seattle Children's Hospital (dba Seattle Children's Research Institute) Transgene genetic tags and methods of use
US11384350B2 (en) 2014-12-15 2022-07-12 The Regents Of The University Of California Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing
CA3008162A1 (en) 2014-12-15 2016-06-23 The Regents Of The University Of California Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
DK3368571T5 (da) 2015-10-30 2024-09-30 Univ California Transformerende, vækstfaktor-beta-responsive polypeptider og fremgangsmåder til anvendelse deraf
US12144850B2 (en) 2016-04-08 2024-11-19 Purdue Research Foundation Methods and compositions for car T cell therapy
AU2018219226B2 (en) 2017-02-07 2024-12-19 Seattle Children's Hospital (dba Seattle Children's Research Institute) Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
ES3010559T3 (en) 2017-02-28 2025-04-03 Endocyte Inc Compositions and methods for car t cell therapy
US11311576B2 (en) 2018-01-22 2022-04-26 Seattle Children's Hospital Methods of use for CAR T cells
WO2019156795A1 (en) * 2018-02-06 2019-08-15 Seattle Children's Hospital (dba Seattle Children's Research Institute) Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
CA3091674A1 (en) 2018-02-23 2019-08-29 Endocyte, Inc. Sequencing method for car t cell therapy
CN112262214A (zh) 2018-04-12 2021-01-22 优莫佳生物制药股份有限公司 病毒载体及包装细胞系
CA3169804A1 (en) * 2020-02-04 2021-08-12 Seattle Children's Hospital (dba Seattle Children's Research Institute) Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells
KR20220163940A (ko) 2020-02-04 2022-12-12 시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 항-디니트로페놀 키메라 항원 수용체
MX2022011673A (es) 2020-03-20 2022-12-13 Lyell Immunopharma Inc Nuevos marcadores de superficie celular recombinantes.
CN115768880A (zh) * 2020-05-06 2023-03-07 亘喜生物科技(上海)有限公司 用于t细胞工程化的组合物和方法
CN111735952B (zh) * 2020-06-04 2023-07-11 北京勤邦科技股份有限公司 一种检测六氯苯的试纸条及方法
KR20230021022A (ko) * 2020-06-08 2023-02-13 시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 항-cd171 키메라 항원 수용체
CA3172530A1 (en) 2021-02-25 2022-09-01 Spencer PARK Ror1 targeting chimeric antigen receptor
CN114019166B (zh) * 2021-09-27 2024-02-27 浙江省食品药品检验研究院 一种检测龙葵素的试纸条及其应用
CA3238005A1 (en) * 2021-11-10 2023-05-19 Outpace Bio, Inc. Chimeric antigen receptors
CN119775406B (zh) * 2025-01-22 2025-11-25 北京赛科希德科技股份有限公司 纤溶酶降解产物d-二聚体抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004113062A (ja) * 2002-09-25 2004-04-15 Teruyuki Nagamune キメラ受容体を有する動物細胞とその利用
WO2016168766A1 (en) * 2015-04-15 2016-10-20 The California Institute For Biomedical Research Optimized chimeric receptor t cell switches and uses thereof
EP3484448B1 (en) * 2016-07-13 2025-04-09 President and Fellows of Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
US11590214B2 (en) * 2016-12-21 2023-02-28 Danmarks Tekniskte Universitet Antigen presenting scaffolds for immune-cell manipulation
CN111148533A (zh) * 2017-09-19 2020-05-12 麻省理工学院 用于嵌合抗原受体t细胞疗法的组合物及其用途

Similar Documents

Publication Publication Date Title
AU2021221785B2 (en) Engineered gamma delta T-cells
JP7573441B2 (ja) ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法
JP2020182458A5 (enExample)
KR20210074274A (ko) 합텐 표지된 세포로의 키메라 항원 수용체 t 세포의 자극을 위한 방법 및 조성물
JP2020188789A (ja) 免疫療法のためのナノ粒子組成物及び方法
CN111936518A (zh) 对fl-ple标记的肿瘤表现出最佳的t细胞功能的荧光素特异性car
KR20190016960A (ko) γδ T-세포 집단의 선택적 확장을 위한 방법 및 그의 조성물
CN109072195A (zh) 具有增强功效的免疫效应细胞疗法
CN109121413A (zh) 使用靶向核酸纳米载体编程治疗性细胞的组合物和方法
JP2006506954A (ja) Tcr及びtirc7に結合する新規な抗体、並びに治療及び診断におけるその使用
CN115397440A (zh) 用半抗原标记细胞刺激嵌合抗原受体t细胞的方法和组合物
JP2023500338A5 (enExample)
JP7785696B2 (ja) 操作されたt細胞受容体および使用の方法
WO2021113558A2 (en) METHODS FOR EXPANDING γδ T-CELL POPULATIONS WITH MULTIVALENT AGENTS AND COMPOSITIONS THEREOF
US12221480B2 (en) Methods for selective expansion of delta-3 gamma delta T-cell populations and compositions thereof
JP2021045150A5 (enExample)
HK40109798A (zh) 制导和导航控制蛋白及其制备和使用方法
HK40097671A (zh) 制导和导航控制蛋白及其制备和使用方法
HK40097672A (zh) 制导和导航控制蛋白及其制备和使用方法
JP2024527963A5 (enExample)
WO2025252993A1 (en) Chimeric antigen receptor targeting glioma-associated antigens
HK40113193A (zh) 靶向ndc80抗原的肽和经改造t细胞受体及使用方法
HK40090148A (zh) 用於得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖
CN118265721A (zh) 靶向ndc80抗原的肽和经改造t细胞受体及使用方法